Browse the complete list of all our published health and social care guidance, including guidelines, NICE advice and quality standards ...

Browse the complete list of all our published health and social care guidance, including guidelines, NICE advice and quality standards ...

Tarlatamamb for treating small-cell lung cancer that has progressed after platinum-based chemotherapy [ID6617] Awaiting development GID-TA11812 Expected publication date: TBC ...

Late stage assessment (LSA) guidance on transcatheter heart valves for transcatheter aortic valve implantation to treat aortic stenosis. Last reviewed: 21 August 2025 NICE has developed tools and ...

Seven other digital technologies - Beat Better, Datos Health, Get Ready, Luscii vitals, Pumping Marvellous Cardiac Rehab Platform, R Plus Health and Sword Move - require more research before they can ...

There is not enough evidence to determine whether price variation is justified between different transcatheter heart valves for transcatheter aortic valve implantation (TAVI) in adults with aortic ...

NICE has recommended a new first-line treatment for adults with advanced bladder cancer, marking a significant breakthrough for patients facing this devastating disease.

This guidance will partially update the following: Type 2 diabetes in adults: management (NG28) Status: In progress Developed as: CG Provisional Schedule Draft guidance consultation: 20 August 2025 - ...

Millions of people are set to benefit from earlier access to newer type 2 diabetes treatments – the biggest shake-up in care for a decade – as part of NICE’s commitment to re-evaluate priority ...

Social care We work with the adult and children's care sectors to develop independent recommendations for social care. We develop health and public health advice and guidance, which allows an ...

Ten transcatheter heart valves were available on the NHS Supply Chain and included in this assessment at the time of publication. All of them had valid CE certification as class 3 implantable devices.

Serplulimab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer [ID6346] In development GID-TA11405 Expected publication date: TBC ...